China SXT Pharmaceuticals, Inc. SEC filings SXTC
China SXT Pharmaceuticals, Inc. has 169 filings in SEC EDGAR's recent list, going back to Dec 4, 2017. Its latest annual report, Form 20-F, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 9, 2026 | — |
| F-3/A | Amendment no. 1 to form f-3 | Aug 28, 2026 | — |
| 424B5 | Prospectus supplement | Jul 24, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 7, 2026 | — |
| 424B5 | Prospectus supplement | Jun 1, 2026 | — |
| 424B5 | Prospectus supplement | Apr 9, 2026 | — |
| 424B5 | Prospectus supplement | Jan 12, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 10, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form f-3 | Nov 10, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 424B5 | Prospectus supplement | May 7, 2025 | — |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 22, 2024 | — |
| S-8 | Employee stock plan registration | Jan 11, 2024 | — |
| 424B7 | Filing | Mar 27, 2023 | — |
| 424B5 | Prospectus supplement | Mar 16, 2022 | — |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| 424B5 | Prospectus supplement | Jan 20, 2022 | — |
| 424B5 | Prospectus supplement | Jan 18, 2022 | — |
| S-8 | Employee stock plan registration | Aug 27, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 2, 2021 | — |
| 424B8 | Prospectus | Nov 5, 2019 | — |
| F-1/A | Amendment no.1 to form f-1 | Jun 21, 2019 | — |
| F-1 | Registration statement (foreign issuer) | May 30, 2019 | — |
| 424B3 | Prospectus | Mar 5, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2018 | — |
| 424B4 | Prospectus | Oct 3, 2018 | — |
| FWP | Free writing prospectus | Sep 27, 2018 | — |
| F-1/A | Filing | Sep 17, 2018 | — |
| F-1/A | Filing | Aug 17, 2018 | — |
| FWP | Free writing prospectus | Jun 7, 2018 | — |
| F-1/A | Filing | May 7, 2018 | — |
| F-1/A | Filing | Apr 20, 2018 | — |
| F-1/A | Filing | Mar 28, 2018 | — |
| F-1/A | Filing | Mar 6, 2018 | — |
| F-1/A | Filing | Jan 19, 2018 | — |
| F-1 | Registration statement (foreign issuer) | Dec 4, 2017 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- Taizhou
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723980
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.